Blood-Pressure Drug Cos. Hit With Suit Over Contamination

Law360 (November 8, 2018, 2:10 PM EST) -- The makers of a generic blood-pressure drug that was recalled due to contamination by a carcinogen "willfully ignored warning signs" about poor safety procedures in a laboratory in India and should have known their drugs were tainted years before testing revealed it this summer, according to a putative consumer class action filed Wednesday in Boston federal court.

Camber Pharmaceuticals Inc. and Hetero Drugs Ltd. turned a blind eye to the problems, the suit alleges, and perhaps even tried to prevent regulators from finding out about them. Employees at a Hetero lab in India that made the drug were caught on video...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Attached Documents

Related Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Subscribers Only

Nature of Suit

Subscribers Only

Judge

Subscribers Only

Date Filed

Subscribers Only

Law Firms

Companies

Government Agencies